158 related articles for article (PubMed ID: 23036934)
1. Relationship of thyroid-stimulating hormone levels to development of dyslipidemia and determination of an ideal cut-off point to start replacement therapy.
Sarzosa Terán V; Astudillo Calle MA
Endocrinol Nutr; 2012 Dec; 59(10):575-82. PubMed ID: 23036934
[TBL] [Abstract][Full Text] [Related]
2. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
Iqbal A; Jorde R; Figenschau Y
J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional study of the association between circulating TSH level and lipid profile in a large Spanish population.
Santos-Palacios S; Brugos-Larumbe A; Guillén-Grima F; Galofré JC
Clin Endocrinol (Oxf); 2013 Dec; 79(6):874-81. PubMed ID: 23550997
[TBL] [Abstract][Full Text] [Related]
4. [Effect of treatment with levothyroxine in the lipid profile of the patients with subclinical hypothyroidism].
Prats Julià M
Endocrinol Nutr; 2009 Jan; 56(1):13-7. PubMed ID: 19627704
[TBL] [Abstract][Full Text] [Related]
5. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study.
Tognini S; Polini A; Pasqualetti G; Ursino S; Caraccio N; Ferdeghini M; Monzani F
Thyroid; 2012 Nov; 22(11):1096-103. PubMed ID: 23050788
[TBL] [Abstract][Full Text] [Related]
6. Thyroid dysfunction and its effect in serum lipids.
Shrestha N
J Nepal Health Res Counc; 2011 Apr; 9(1):33-7. PubMed ID: 22929710
[TBL] [Abstract][Full Text] [Related]
7. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).
Meier C; Staub JJ; Roth CB; Guglielmetti M; Kunz M; Miserez AR; Drewe J; Huber P; Herzog R; Müller B
J Clin Endocrinol Metab; 2001 Oct; 86(10):4860-6. PubMed ID: 11600554
[TBL] [Abstract][Full Text] [Related]
8. Evaluation response and effectiveness of thyroid hormone replacement treatment on lipid profile and function in elderly patients with subclinical hypothyroidism.
Arinzon Z; Zuta A; Peisakh A; Feldman J; Berner Y
Arch Gerontol Geriatr; 2007; 44(1):13-9. PubMed ID: 16621071
[TBL] [Abstract][Full Text] [Related]
9. Subclinical hypothyroidism in patients with polycystic ovary syndrome: distribution and its association with lipid profiles.
Huang R; Zheng J; Li S; Tao T; Liu W
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():52-6. PubMed ID: 24768234
[TBL] [Abstract][Full Text] [Related]
10. Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients.
Klose M; Marina D; Hartoft-Nielsen ML; Klefter O; Gavan V; Hilsted L; Rasmussen AK; Feldt-Rasmussen U
J Clin Endocrinol Metab; 2013 Sep; 98(9):3802-10. PubMed ID: 23796569
[TBL] [Abstract][Full Text] [Related]
11. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
Ozcan O; Cakir E; Yaman H; Akgul EO; Erturk K; Beyhan Z; Bilgi C; Erbil MK
Clin Endocrinol (Oxf); 2005 Aug; 63(2):203-6. PubMed ID: 16060915
[TBL] [Abstract][Full Text] [Related]
12. Serum Thyroid-Stimulating Hormone Levels and Body Mass Index Percentiles in Children with Primary Hypothyroidism on Levothyroxine Replacement.
Shaoba A; Basu S; Mantis S; Minutti C
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(4):337-343. PubMed ID: 28766504
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia.
Diekman T; Lansberg PJ; Kastelein JJ; Wiersinga WM
Arch Intern Med; 1995 Jul; 155(14):1490-5. PubMed ID: 7605150
[TBL] [Abstract][Full Text] [Related]
14. Relation between lipoprotein subfractions and TSH levels in the cardiovascular risk among women with subclinical hypothyroidism.
Hernández-Mijares A; Jover A; Bellod L; Bañuls C; Solá E; Veses S; Víctor VM; Rocha M
Clin Endocrinol (Oxf); 2013 May; 78(5):777-82. PubMed ID: 23039873
[TBL] [Abstract][Full Text] [Related]
15. Levothyroxine medication is associated with adiposity independent of TSH.
Ruhla S; Arafat AM; Osterhoff M; Weickert MO; Mai K; Spranger J; Schöfl C; Pfeiffer AF; Möhlig M
Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):351-4. PubMed ID: 22639395
[TBL] [Abstract][Full Text] [Related]
16. Effect of the normalization of TSH and free T4 on lipid profile in a pediatric population with primary hypothyroidism.
Rivera-Hernández A; Rojas-Martínez R; Mendoza-Zubieta V; Balcázar-Hernández L
Andes Pediatr; 2021 Feb; 92(1):59-66. PubMed ID: 34106184
[TBL] [Abstract][Full Text] [Related]
17. Association of Subclinical Hypothyroidism with Dyslipidemia and Increased Carotid Intima-Media Thickness in Children.
Unal E; Akın A; Yıldırım R; Demir V; Yildiz İ; Haspolat YK
J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):144-149. PubMed ID: 28008862
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hypothyroidism in patients with dyslipidemia: Tehran Thyroid Study (TTS).
Khazan M; Amouzegar A; Gharibzadeh S; Mehran L; Tohidi M; Azizi F
Horm Metab Res; 2014 Dec; 46(13):980-4. PubMed ID: 25369072
[TBL] [Abstract][Full Text] [Related]
19. Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile.
Tagliaferri M; Berselli ME; Calò G; Minocci A; Savia G; Petroni ML; Viberti GC; Liuzzi A
Obes Res; 2001 Mar; 9(3):196-201. PubMed ID: 11323445
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between hypothyroidism and cholesterol out of the records of 1756 patients].
Sampaolo G; Campanella N; Catozzo V; Ferretti M; Vichi G; Morosini P
Recenti Prog Med; 2014 Feb; 105(2):79-82. PubMed ID: 24625905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
